Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of this study is to discover the immune and oncogenomic features that distinguish patients who respond to teclistamab from patients who are primarily resistant. Moreover, phenotypic and genotypic characteristics that occur with secondary resistance to teclistamab will be analyzed.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Analysis of bone marrow | Experimental | Analysis of bone marrow in patients initiated treatment by Teclistamab for 18 cycles |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Bone marrow sampling | Other | Bone marrow sampling collected at 12 weeks after initiation treatment (day 1 cycle 4) |
|
| Measure | Description | Time Frame |
|---|---|---|
| Response to teclistamab at 12 weeks | response according to International Myeloma Working Group criteria | at day 1 Cycle 4 (each cycle is 28 days) |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Hervé AVET LOISEAU, MD, PhD | Contact | +33 531 156 142 | 33 | avetloiseau.herve@iuct-oncopole.fr |
| Name | Affiliation | Role |
|---|---|---|
| Hervé AVET LOISEAU, MD, PhD | University Hospital, Toulouse | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CHU d'Amiens | Recruiting | Amiens | France | 80054 | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| CHU de Caen | Recruiting | Caen | France | 14033 | France |
|
| Polyclinique du Parc Drevon | Recruiting | Dijon | France | 21000 | France |
|
| CH Annecy Genevois | Recruiting | Epagny Metz- Tessy | France | 74370 | France |
|
| CHU de Lille | Recruiting | Lille | France | 59037 | France |
|
| Centre Léon Bérard | Recruiting | Lyon | France | 69373 | France |
|
| CHU de Montpellier | Recruiting | Montpellier | France | 34295 | France |
|
| Hôpital Saint-Louis | Recruiting | Paris | France | 75010 | France |
|
| Hôpital Saint-Antoine | Recruiting | Paris | France | 75012 | France |
|
| Hôpital Necker | Recruiting | Paris | France | 75015 | France |
|
| CHU de Bordeaux | Recruiting | Pessac | France | 33600 | France |
|
| CHU de Lyon | Recruiting | Pierre-Bénite | France | 69495 | France |
|
| CHU de Poitiers | Recruiting | Poitiers | France | 86021 | France |
|
| CHU de Rennes | Recruiting | Rennes | France | 35033 | France |
|
| CH Saint-Etienne | Recruiting | Saint-Priest-en-Jarez | France | 42271 | France |
|
| CHU de Toulouse | Recruiting | Toulouse | France | 31059 | France |
|
| CHU de Tours | Recruiting | Tours | France | 37044 | France |
|
| CHRU Nancy | Recruiting | Vandœuvre-lès-Nancy | France | 54500 | France |
|
| ID | Term |
|---|---|
| D009101 | Multiple Myeloma |
| ID | Term |
|---|---|
| D054219 | Neoplasms, Plasma Cell |
| D009370 | Neoplasms by Histologic Type |
| D009369 | Neoplasms |
| D020141 | Hemostatic Disorders |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D010265 | Paraproteinemias |
| D001796 | Blood Protein Disorders |
| D006402 | Hematologic Diseases |
| D006425 | Hemic and Lymphatic Diseases |
| D006474 | Hemorrhagic Disorders |
| D008232 | Lymphoproliferative Disorders |
| D007160 | Immunoproliferative Disorders |
| D007154 | Immune System Diseases |
Not provided
Not provided